June 27 (Reuters) - Anagenics Ltd (AN1) :
- FY23 CONTINUING REVENUE AND OTHER INCOME OF A$9.6M, UP 24% ON FY22
- SEES TOTAL REVENUE AND OTHER INCOME OF A$9.6M FOR FY23
- EXPECTS FY23 TOTAL UNDERLYING EBITDA LOSS OF A$1.7M
- CURRENTLY IN DUE DILIGENCE ON 2 POTENTIAL SYNERGISTIC ACQUISITIONS TARGETING CLOSE IN Q1 FY24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.481M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2936195 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 207362 | 1 |
View Market Depth
| Last trade - 10.00am 29/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable